Index | S&P Health Care Select Sector |
Investment focus | Equity, United States, Health Care |
Fund size | GBP 308 m |
Total expense ratio | 0.15% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 11.94% |
Inception/ Listing Date | 7 July 2015 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | SPDR ETF |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | State Street Global Advisors Europe Limited |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Ernst & Young |
Fiscal Year End | 31 March |
Swiss representative | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | State Street Bank and Trust Company |
Securities lending | Yes |
Securities lending counterparty | BARCLAYS BANK PLC|BARCLAYS CAPITAL SECURITIES LIMITED|BNP PARIBAS|BNP PARIBAS ARBITRAGE SNC|CITIGROUP GLOBAL MARKETS LIMITED|CREDIT SUISSE INTERNATIONAL|GOLDMAN SACHS INTERNATIONAL|HSBC BANK PLC|ING BANK NV|JP MORGAN SECURITIES PLC|MACQUARIE BANK LIMITED|MERRILL LYNCH INTERNATIONAL|MORGAN STANLEY & CO. INTERNATIONAL PLC.|NOMURA INTERNATIONAL PLC|RBC EUROPE LIMITED|SOCIETE GENERALE SA|UBS AG |
Eli Lilly & Co. | 12.37% |
UnitedHealth Group | 9.55% |
Johnson & Johnson | 6.90% |
AbbVie, Inc. | 6.17% |
Merck & Co., Inc. | 5.09% |
Thermo Fisher Scientific, Inc. | 4.18% |
Abbott Laboratories | 3.51% |
Danaher Corp. | 3.16% |
Intuitive Surgical | 3.08% |
Amgen, Inc. | 3.06% |
United States | 95.88% |
Ireland | 2.47% |
Other | 1.65% |
Health Care | 98.35% |
Other | 1.65% |
YTD | +5.98% |
1 month | -4.10% |
3 months | -4.79% |
6 months | -1.38% |
1 year | +10.29% |
3 years | +18.27% |
5 years | +59.72% |
Since inception (MAX) | +162.92% |
2023 | -3.85% |
2022 | +9.46% |
2021 | +27.19% |
2020 | +9.30% |
Volatility 1 year | 11.94% |
Volatility 3 years | 16.05% |
Volatility 5 years | 19.21% |
Return per risk 1 year | 0.86 |
Return per risk 3 years | 0.36 |
Return per risk 5 years | 0.51 |
Maximum drawdown 1 year | -6.43% |
Maximum drawdown 3 years | -15.21% |
Maximum drawdown 5 years | -19.77% |
Maximum drawdown since inception | -19.77% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | ZPDH | - - | - - | - |
Stuttgart Stock Exchange | EUR | ZPDH | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | SXLVN MM | SXLVN.MX | |
Borsa Italiana | EUR | SXLV | SXLV IM INZPDHE | SXLV.MI | BNP DRW Flow Traders Optiver Susquehanna Virtu |
Euronext Amsterdam | EUR | SXLV | SXLV NA INZPDHE | SXLV.AS | BNP DRW Flow Traders Optiver Susquehanna Virtu |
London Stock Exchange | USD | SXLV | SXLV LN INZPDHU | SXLV.L | BNP DRW Flow Traders Old Mission Europe LLP Optiver Virtu Financial |
London Stock Exchange | GBP | GXLV | GXLV LN INZPDHP | GXLV.L | BNP DRW Flow Traders Old Mission Europe LLP Optiver Virtu Financial |
SIX Swiss Exchange | USD | SXLV | SXLV SE INZPDHU | SXLV.S | BNP DRW Finovesta Flow Traders Optiver Virtu Financial |
XETRA | EUR | ZPDH | ZPDH GY INZPDHE | ZPDH.DE | BNP Flow Traders Optiver |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2,285 | 0.15% p.a. | Accumulating | Full replication |
Xtrackers MSCI USA Health Care UCITS ETF 1D | 585 | 0.12% p.a. | Distributing | Full replication |
iShares Nasdaq US Biotechnology UCITS ETF | 440 | 0.35% p.a. | Accumulating | Sampling |
Invesco US Health Care Sector UCITS ETF | 437 | 0.14% p.a. | Accumulating | Swap-based |
Invesco Nasdaq Biotech UCITS ETF | 295 | 0.40% p.a. | Accumulating | Swap-based |